Navigation Links
GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
Date:8/20/2007

- Dr. Liew awarded Malaysia's Darjah Yang Mulia Pangkuan Negeri -

TORONTO, Aug. 20 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing simple blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that its co-founder and Chief Scientific Officer, Dr. CC Liew, was awarded the Darjah Yang Mulia Pangkuan Negeri (DMPN), a State Honour given by the Governor of Penang in Malaysia. Conferred on prominent people who have served the nation or who excel in their professions, this honour carries with it the title of "Datuk", which is similar to a knighthood in Britain. This award is limited to 150 living persons at any given time.

"We are very proud that this honour has been bestowed on Dr. Liew for demonstrating excellence in the field of disease-specific genomics," said K. Wayne Marshall, MD, PhD, President and Chief Executive Officer of GeneNews. "Through Dr. Liew, GeneNews has formed a strong relationship with the Malaysian scientific community. With Malaysia having made a commitment to becoming a major player in the biotechnology sector in South East Asia, Dr. Liew's growing reputation will only further enhance our ability to collaborate with researchers in this region."

In addition to his role as Chief Scientist Officer of GeneNews, Dr. Liew currently holds the positions of Visiting Professor of Medicine and Founding Director of the Cardiovascular Genome Unit at Brigham and Women's Hospital, Harvard Medical School, and Professor Emeritus at the University of Toronto.

About GeneNews

GeneNews is focussed on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle(TM) in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' first product in development, ColonSentry(TM), is a blood-based test that can detect colon cancer. For more information on GeneNews, visit http://www.genenews.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE GeneNews Limited

Copyright©2007 PR Newswire.

Related biology technology :

1. Small Tree Communications awarded $2.85M defense contract
2. Alfalight awarded $1.7M from Army Research Lab
3. Mirus Bio awarded patent on RNA delivery
4. UW Biomedical Engineering awarded $2.9 million research grant
5. Two companies awarded state tech grants
6. Alfalight awarded $4.5 million Army Research contract
7. UW-Madison awarded $20 million grant for protein research
8. Esker awarded patent for DeliveryWare Rules Engine
9. Wisconsin technology companies awarded over $24 million in government funding
10. ConjuGon Awarded $250,000
11. Web-based reporting credited with states top healthcare ranking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Feb. 17, 2017  If only one in ... a mutation-conferring resistance to chemotherapy, thousands of cancer ... has focused on finding these mutations in ever-smaller ... circulating tumor DNA in blood — to guide ... Unfortunately, however, detecting these genetic anomalies ...
(Date:2/16/2017)... MI (PRWEB) , ... February 16, 2017 , ... Avomeen ... p.m. The event will be held at Avomeen Analytical Services (4840 Venture Dr., ... a MichBio member organization. They provide an opportunity to interact with peers, make new ...
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... 2017 Patient Care services ... telemedicine application, new and leading edge therapies and ... boom worldwide. The healthcare sector as whole continues ... and new therapies for companies such as Reliq ... Biosciences, Inc. (NASDAQ: CLRB ), Cytori ...
Breaking Biology Technology:
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/19/2017)... CLARA, Calif. , Jan. 19, 2017 /PRNewswire/ ... company enhancing user experience and security for consumer ... of next-generation payment processing systems and cybersecurity solutions, ... more banks, enterprises and financial institutions worldwide to ... part of the end-to-end secure user authentication platforms ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
Breaking Biology News(10 mins):